Universe Pharmaceuticals Inc.
UPC
Rank in Stocks
#32967
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise... Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
Share Price
$1.60
Last synced: 2026-11-09
Market Cap
$1.01M
Change (1 day)
15.11%
Change (1 year)
-55.56%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Universe Pharmaceuticals Inc. (UPC)
Category
Healthcare
Operating Margin for Universe Pharmaceuticals Inc. (UPC)
Operating Margin as of November 2026 TTM: -11.78%
According to Universe Pharmaceuticals Inc.'s latest financial reports, its current operating margin (TTM) is -11.78%. At the end of 2025 the company had an operating margin of -16.33%.
Operating Margin history for Universe Pharmaceuticals Inc. from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -11.78% | -27.86% |
| 2025 | -16.33% | -53.12% |
| 2024 | -34.83% | 218.96% |
| 2023 | -10.92% | -37.56% |
| 2022 | -17.49% | -161.76% |
| 2021 | 28.32% | -15.18% |
| 2020 | 33.39% | 13.76% |
| 2019 | 29.35% | -13.35% |
| 2018 | 33.87% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -101.65% |
DE
|
|
| 19.68% | -101.67% |
DE
|
|
| 13.26% | -101.13% |
JP
|
|
| 17.08% | -101.45% |
CH
|
|
| 14.92% | -101.27% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Universe Pharmaceuticals Inc.'s operating margin
What is Universe Pharmaceuticals Inc.'s operating margin?
Universe Pharmaceuticals Inc.'s operating margin is -11.78%, as of Nov 2026.
What was Universe Pharmaceuticals Inc.'s operating margin in 2025?
In 2025, Universe Pharmaceuticals Inc.'s operating margin was -16.33%, compared with -34.83% in 2024.
How has Universe Pharmaceuticals Inc.'s operating margin changed since 2020?
From 2020 to 2025, Universe Pharmaceuticals Inc.'s operating margin was highest in 2020 (33.39%) and lowest in 2024 (-34.83%).
How does Universe Pharmaceuticals Inc.'s operating margin compare with similar companies?
Universe Pharmaceuticals Inc.'s operating margin (-11.78%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.